CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
6.99
-0.07 (-0.99%)
At close: Jun 18, 2025, 4:00 PM
6.91
-0.08 (-1.14%)
After-hours: Jun 18, 2025, 7:32 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $60.83 million as of June 18, 2025. Its market cap has decreased by -61.08% in one year.
Market Cap
60.83M
Enterprise Value
25.59M
1-Year Change
-61.08%
Ranking
Category
Stock Price
$6.99
Market Cap Chart
Since June 30, 2008, CervoMed's market cap has increased from $1.50M to $60.83M, an increase of 3,955.47%. That is a compound annual growth rate of 24.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 17, 2025 | 61.40M | 218.13% |
Dec 31, 2024 | 19.30M | -55.43% |
Dec 29, 2023 | 43.30M | 320.39% |
Dec 30, 2022 | 10.30M | -66.88% |
Dec 31, 2021 | 31.10M | -38.90% |
Dec 31, 2020 | 50.90M | 2,213.64% |
Dec 31, 2019 | 2.20M | -67.16% |
Dec 31, 2018 | 6.70M | -60.82% |
Dec 29, 2017 | 17.10M | -26.92% |
Dec 30, 2016 | 23.40M | 25.81% |
Dec 31, 2015 | 18.60M | -69.71% |
Dec 31, 2014 | 61.40M | 361.65% |
Dec 31, 2013 | 13.30M | -22.22% |
Dec 31, 2012 | 17.10M | -60.87% |
Dec 30, 2011 | 43.70M | 54.42% |
Dec 31, 2010 | 28.30M | -75.81% |
Dec 31, 2009 | 117.00M | 39.62% |
Dec 31, 2008 | 83.80M | 5,486.67% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 716.45B |
Johnson & Johnson | 369.86B |
Novo Nordisk | 343.59B |
AbbVie | 331.50B |
UnitedHealth Group | 279.70B |
Novartis AG | 232.80B |
Abbott Laboratories | 232.16B |
AstraZeneca | 228.09B |